Adverum Biotechnologies Inc (NASDAQ:ADVM)

0.893
Delayed Data
As of May 27
 +0.0191 / +2.19%
Today’s Change
0.80
Today|||52-Week Range
3.86
-49.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues833.0K70.0K0.000.00
 
 
 
Depreciation And Amortization262.0K389.0K965.0K959.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----965.0K-959.0K
 
 
 
General Expenses19.0M16.4M14.7M15.1M
 
 
 
 
 
Research And Development14.5M11.6M10.1M9.0M
 
 
 
 
 
Total Operating Expenses19.3M16.8M15.7M16.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.5M-16.8M-15.7M-16.1M
 
 
 
 
 
Extraordinary Charge-5.0M0.000.000.00
 
 
Other Expenses1.3M1.1M1.2M1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.2M-15.7M-14.5M-15.0M
 
 
 
 
 
Income Taxes-1.3M0.000.000.00
 
 
Net Income-21.0M-15.7M-14.5M-15.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS62.5M62.9M63.1M63.7M
 
 
 
 
 
Shares To Calculate EPS Diluted62.5M62.9M63.1M63.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.25-$0.23-$0.23
 
 
 
 
 
EPS Diluted-$0.34-$0.25-$0.23-$0.23